Merck pleaded guilty and paid $950 million over illegal Vioxx marketing
Company: Merck & Co., Inc.
Summary
Merck Sharp & Dohme agreed to pay $950 million to resolve criminal and civil matters involving Vioxx. Merck pleaded guilty to introducing a misbranded drug into interstate commerce; the civil settlement also addressed allegations of off-label promotion and false statements concerning cardiovascular safety. Source: https://www.justice.gov/archives/opa/pr/us-pharmaceutical-company-merck-sharp-dohme-pay-nearly-one-billion-dollars-over-promotion